Sort
50,496 grants matching “lung cancer”
MOCSLID-CCC
$390,912Donald P Tashkin · University Of California Los Angeles · R01 · FY2010 · HL
c-Myc modulation and its implications in EGFR-targeted cancer therapy
$390,871Shi-Yong Sun · Emory University · R01 · FY2023 · CA
Eastern Cooperative Oncology Group
$390,865David H Johnson · Vanderbilt University · U10 · FY2008 · CA
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening
$390,841Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Communication of genomic information in clinical and online contexts
$390,838Susan Persky · National Human Genome Research Institute · ZIA · FY2012 · HG
Validation of EGFR Protein Complexes as Molecular Diagnostics
$390,763Eric B. Haura · H. Lee Moffitt Cancer Ctr & Res Inst · UH2 · FY2016 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$390,763Trudy Gale Oliver · Duke University · R01 · FY2024 · CA
Population-Based Assessment of Cancer Trial Generalizability in the Elderly
$390,756Elizabeth B Lamont · Harvard Medical School · R01 · FY2011 · CA
Novel Receptor-Targeting Peptides for Melanoma Therapy
$390,755Yubin Miao · University Of Colorado Denver · R01 · FY2021 · CA
Novel Receptor-Targeting Peptides for Melanoma Therapy
$390,754Yubin Miao · University Of Colorado Denver · R01 · FY2020 · CA
Mechanisms of linkage of stem and invasive phenotypes during metastatic colonization
$390,738Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · P01 · FY2023 · CA
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
$390,734Jonathan D. Licht · University Of Florida · R01 · FY2020 · CA
Metabolic control of DNA repair in pulmonary fibrosis
$390,690Ross S Summer · Thomas Jefferson University · R01 · FY2020 · HL
EXTRACELLULAR VESICLES (EVS) AS TUMOR-TARGETING THERANOSTIC FOR LUNG CANCER
$390,686University Of Missouri System · · FY2022 · Defense Health Agency
The protective role of Nrf2 in arsenic-induced toxicity and carcinogenicity
$390,682Donna D Zhang · University Of Arizona · R01 · FY2008 · ES
Metabolic control of DNA repair in pulmonary fibrosis
$390,676Ross S Summer · Thomas Jefferson University · R01 · FY2019 · HL
Investigating the prognostic role of intrinsic immune evasion mechanisms in HNSCC
$390,669Xuefeng Wang · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · DE
Targeting Metabolic Liabilities in Cancer
$390,657Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2020 · CA
Targeting Metabolic Liabilities in Cancer
$390,657Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2021 · CA
Targeting Metabolic Liabilities in Cancer
$390,657Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2022 · CA
Targeting Metabolic Liabilities in Cancer
$390,657Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2018 · CA
Evaluating New Nicotine Standards for Cigarettes - Core B
$390,651Stephen S Hecht · Wake Forest University Health Sciences · U54 · FY2022 · DA
HDGF: a novel biomarker and therapetic target of lung cancer
$390,636Li Mao · University Of Maryland Baltimore · R01 · FY2012 · CA
Host control mechanisms against K. pneumoniae infection in the lungs
$390,626Janet S Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · HL
Novel inhibitor for oncogenic RAS for lung cancer
$390,583Gary A Piazza · Auburn University At Auburn · R01 · FY2022 · CA